Dear PPSI followers:
Please send your letter, SAMPLE BELOW AND LINK HERE> hmo-insurances-ltr-re-naloxone, to as many of the insurance companies possible-with your name, phone number and email.
HMO addresses and emails obtained via HICAP (California based)
(insert sample insurance company
PO Box xxxx
anytown, any-state, correct zip)
Dear Medical Director:
I am writing to you, as _______ and as _________ regarding Assembly bill 1535, Richard Bloom, signed by Governor Brown into California law in 2015, which provides Naloxone Hydrochloride, all injectable, nasal, 2 types and auto injector to patients to prevent overdoses on opioid medications.
Many Pharmacies are not stocking Naloxone, in any form. One of the issues is that insurance companies, managed care organizations, pharmacy benefit managers and others will not reimburse for this life saving emergency use product.
I want to know if your company has Naloxone on its formulary and if so, which products, and are they reimbursable? (Under California AB 1535 Bloom).
Please take a minute and check off which product your company uses.
_____ Naloxone Nasal inhaler
_____ Naloxone nasal inhaler-newly approved by FDA
_____ Naloxone injectable with syringe
_____ Naloxone syringe combination–pre filled
_____ Naloxone auto injector–2 pack
In addition to reimbursement for the product that is on your formulary, is there any professional fee for educating the patient, record keeping, consultation and drug interactions ?
CDC has reported that 46,280 overdoses in 2015 from opioids and other products and as you can see, by analyses,” FDA requires strong warnings on opioid analgesics, prescription opioid cough products, benzodiazepines labeling related to serious risk and death from combined use.”
I look forward to hearing from you, as I am interested in what is available in my community for my patients and customers.